Axel Kahn

25.0k total citations · 8 hit papers
268 papers, 20.7k citations indexed

About

Axel Kahn is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Axel Kahn has authored 268 papers receiving a total of 20.7k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Molecular Biology, 72 papers in Surgery and 65 papers in Genetics. Recurrent topics in Axel Kahn's work include Pancreatic function and diabetes (65 papers), Erythrocyte Function and Pathophysiology (40 papers) and Metabolism, Diabetes, and Cancer (35 papers). Axel Kahn is often cited by papers focused on Pancreatic function and diabetes (65 papers), Erythrocyte Function and Pathophysiology (40 papers) and Metabolism, Diabetes, and Cancer (35 papers). Axel Kahn collaborates with scholars based in France, United States and United Kingdom. Axel Kahn's co-authors include Sophie Vaulont, Gaël Nicolas, Carole Beaumont, Isabelle Devaux, Lydie Viatte, Myriam Bennoun, Jamel Chelly, Sophie Vaulont, Xavier Bigard and Caroline Chauvet and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Axel Kahn

260 papers receiving 20.1k citations

Hit Papers

The gene encoding the iron regulatory peptide hepcidin... 1988 2026 2000 2013 2002 2001 2002 1998 1999 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Axel Kahn France 65 10.5k 4.9k 3.9k 3.3k 3.2k 268 20.7k
Yuet Wai Kan United States 75 12.1k 1.1× 3.3k 0.7× 4.8k 1.2× 1.3k 0.4× 2.8k 0.9× 215 19.6k
James Douglas Engel United States 72 14.5k 1.4× 1.9k 0.4× 2.1k 0.5× 1.1k 0.3× 2.6k 0.8× 225 19.0k
Tomohiro Kurosaki Japan 96 10.6k 1.0× 1.3k 0.3× 2.5k 0.6× 701 0.2× 1.2k 0.4× 316 28.3k
C. Peter Downes United Kingdom 77 19.3k 1.8× 920 0.2× 1.8k 0.5× 2.8k 0.9× 1.3k 0.4× 196 26.5k
Joachim Herz United States 95 15.9k 1.5× 1.6k 0.3× 1.4k 0.4× 6.2k 1.9× 3.7k 1.2× 284 35.7k
Koiti Titani Japan 74 10.9k 1.0× 3.6k 0.7× 828 0.2× 797 0.2× 2.8k 0.9× 291 19.1k
Dudley K. Strickland United States 75 8.7k 0.8× 3.0k 0.6× 862 0.2× 2.4k 0.7× 1.1k 0.4× 257 21.3k
A. Ullrich Germany 92 22.5k 2.1× 1.5k 0.3× 1.4k 0.4× 2.8k 0.9× 2.6k 0.8× 193 33.0k
William A. Gahl United States 71 6.5k 0.6× 1.4k 0.3× 1.1k 0.3× 805 0.2× 2.7k 0.8× 487 18.3k
Antonio Cao Italy 53 4.5k 0.4× 3.9k 0.8× 4.9k 1.2× 629 0.2× 2.6k 0.8× 303 12.1k

Countries citing papers authored by Axel Kahn

Since Specialization
Citations

This map shows the geographic impact of Axel Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Kahn more than expected).

Fields of papers citing papers by Axel Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Kahn. The network helps show where Axel Kahn may publish in the future.

Co-authorship network of co-authors of Axel Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Kahn. A scholar is included among the top collaborators of Axel Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Kahn. Axel Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferry, Luc & Axel Kahn. (2010). Faut-il légaliser l'euthanasie ?.
2.
Andreu, Pauline, Sabine Colnot, Cécile Godard, et al.. (2006). Identification of the IFITM Family as a New Molecular Marker in Human Colorectal Tumors. Cancer Research. 66(4). 1949–1955. 111 indexed citations
3.
Viatte, Lydie, Myriam Bennoun, Christophe Houbron, et al.. (2006). Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood. 108(4). 1402–1405. 205 indexed citations
4.
Kahn, Axel. (2005). L’impérialisme des micro-ARN s’étend maintenant au cancer. médecine/sciences. 21. 687–689. 5 indexed citations
5.
Kahn, Axel. (2005). L’impérialisme des micro-ARN s’étend maintenant au cancer. médecine/sciences. 21(8-9). 687–689. 5 indexed citations
6.
Kahn, Axel. (2003). L’hélice de la vie. médecine/sciences. 19(4). 491–495. 1 indexed citations
7.
Caliot, Élise, Marcelle Bens, Anna Bogdanova, et al.. (2002). Lymphoepithelial Interactions Trigger Specific Regulation of Gene Expression in the M Cell-Containing Follicle-Associated Epithelium of Peyer’s Patches. The Journal of Immunology. 168(8). 3713–3720. 29 indexed citations
8.
Leroux, Alena, Luísa Mota‐Vieira, & Axel Kahn. (2001). Transcriptional and translational mechanisms of cytochrome b5 reductase isoenzyme generation in humans. Biochemical Journal. 355(2). 529–529. 19 indexed citations
9.
Mignon, Alexandre, Nicolas Rouquet, Monique Fabrè, et al.. (1999). LPS Challenge in D-galactosamine–Sensitized Mice Accounts for Caspase-dependent Fulminant Hepatitis, not for Septic Shock. American Journal of Respiratory and Critical Care Medicine. 159(4). 1308–1315. 154 indexed citations
10.
Portes, Vincent des, Pierre Billuart, Marie Claude Vinet, et al.. (1998). A Novel CNS Gene Required for Neuronal Migration and Involved in X-Linked Subcortical Laminar Heterotopia and Lissencephaly Syndrome. Cell. 92(1). 51–61. 589 indexed citations breakdown →
11.
Spitz, François, Marjo Salminen, Josiane Demignon, et al.. (1997). A Combination of MEF3 and NFI Proteins Activates Transcription in a Subset of Fast-Twitch Muscles. Molecular and Cellular Biology. 17(2). 656–666. 62 indexed citations
12.
Vallet, Véronique, Bénédicte Antoine, Philippe Chafey, Alain Vandewalle, & Axel Kahn. (1995). Overproduction of a Truncated Hepatocyte Nuclear Factor 3 Protein Inhibits Expression of Liver-Specific Genes in Hepatoma Cells. Molecular and Cellular Biology. 15(10). 5453–5460. 44 indexed citations
13.
Martinez, Antoine, et al.. (1995). Upstream Stimulatory Factor Proteins Are Major Components of the Glucose Response Complex of the L-type Pyruvate Kinase Gene Promoter. Journal of Biological Chemistry. 270(6). 2640–2643. 105 indexed citations
14.
Hugnot, Jean‐Philippe, et al.. (1993). Striking conservation of the brain-specific region of the dystrophin gene. Mammalian Genome. 4(7). 393–396. 4 indexed citations
15.
Chelly, Jamel, et al.. (1988). Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature. 333(6176). 858–860. 640 indexed citations breakdown →
16.
Maire, Pascal, et al.. (1987). Characterization of three optional promoters in the 5′ region of the human aldolase A gene. Journal of Molecular Biology. 197(3). 425–438. 64 indexed citations
17.
Uzan, Georges, Gilles Courtois, Claude Besmond, et al.. (1984). Analysis of fibrinogen genes in patients with congenital afibrinogenemia. Biochemical and Biophysical Research Communications. 120(2). 376–383. 21 indexed citations
18.
Kahn, Axel, et al.. (1982). [23] Pyruvate kinases from human erythrocytes and liver. Methods in enzymology on CD-ROM/Methods in enzymology. 90 Pt E. 131–140. 46 indexed citations
19.
Kahn, Axel, et al.. (1982). Modifications of Phosphoproteins and Protein Kinases Occurring with in vitro Aging of Cultured Human Cells. Gerontology. 28(6). 360–370. 10 indexed citations
20.
Marie, Joëlle, Hervé Garreau, & Axel Kahn. (1977). Evidence for a postsynthetic proteolytic transformation of human erythrocyte pyruvate kinase into L‐type enzyme. FEBS Letters. 78(1). 91–94. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026